Loading clinical trials...
Loading clinical trials...
Effect of COX-2 Inhibition on Allergen-induced Airway Obstruction in Subjects With Asthma
Conditions
Interventions
Etoricoxib
Locations
1
Sweden
Karolinska University Hospital
Stockholm, Sweden
Start Date
October 1, 2009
Primary Completion Date
April 1, 2012
Completion Date
April 1, 2012
Last Updated
April 24, 2013
NCT02327897
NCT07486401
NCT07219173
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
Barbro Dahlen
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions